Related Experiment Video
Updated: Jul 13, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Smac/DIABLO and colon cancer
Y M Anguiano-Hernandez1, A Chartier, S Huerta
1UT Southwestern Medical Center/VA North Texas Health Care System, Department of Gastrointestinal and Endocrine Surgery, Dallas, TX 75216, USA.
Anti-Cancer Agents in Medicinal Chemistry
|July 17, 2007
Summary
Second Mitochondria-Derived Activator of Caspases (Smac/DIABLO) plays a role in apoptosis regulation. Decreased Smac/DIABLO levels may contribute to chemoresistance in colon cancer, impacting therapeutic strategies.
Area of Science:
- Cellular biology
- Molecular oncology
- Cancer research
Background:
- Apoptosis is programmed cell death crucial for tissue homeostasis.
- Cancer involves altered apoptosis, leading to malignant growth.
- Tumor cells resist apoptosis via anti-apoptotic proteins or defective pro-apoptotic pathways.
Purpose of the Study:
- To review the role of Smac/DIABLO in colon carcinogenesis.
- To explore Smac/DIABLO's potential as a diagnostic and therapeutic target.
Main Methods:
- Literature review of existing evidence on Smac/DIABLO and colon cancer.
- Analysis of Smac/DIABLO's function in apoptosis regulation and IAP inhibition.
Main Results:
- Smac/DIABLO induces apoptosis by antagonizing Inhibitors of Apoptosis Proteins (IAPs).
- Decreased Smac/DIABLO levels are implicated in chemoresistance in advanced colon cancer.
- The precise role of Smac/DIABLO in colorectal carcinogenesis requires further investigation.
Conclusions:
- Smac/DIABLO is a key regulator of apoptosis and a potential target in cancer therapy.
- Understanding Smac/DIABLO's role in colon cancer may improve chemoradiation resistance strategies.
- Further research is needed to define Smac/DIABLO's diagnostic and therapeutic significance in colorectal carcinogenesis.
